GlaxoSmithKline Pharmaceuticals
₹2,382.4
+95.4 (4.17%)
- Advice
- Hold
18 May, 2024 11:44 BSE: 500660
NSE: GLAXOISIN: INE159A01016
Start SIP in GlaxoSmithKline Pharmaceuticals
Start SIPGlaxoSmithKline Pharmaceuticals Performance
Day Range
- Low 2,346
- High 2,401
52 Week Range
- Low 1,265
- High 2,524
- Open Price2,385
- Previous Close2,287
- Volume106374
GlaxoSmithKline Pharmaceuticals Financials
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 911 | 805 | 953 | 738 | 782 |
| Operating Expenses Qtr Cr | 656 | 587 | 667 | 597 | 615 |
| Operating Profit Qtr Cr | 255 | 218 | 287 | 141 | 167 |
| Depreciation Qtr Cr | 18 | 17 | 18 | 16 | 17 |
| Interest Qtr Cr | 1 | 0 | 0 | 0 | 1 |
| Tax Qtr Cr | 76 | 20 | 81 | 48 | 56 |
| Net Profit Qtr Cr | 193 | 45 | 216 | 131 | 131 |
GlaxoSmithKline Pharmaceuticals Technicals
EMA & SMA
Current Price
₹2,382.4
+95.4 (4.17%)
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹2,037.57
- 50 Day
- ₹2,027.42
- 100 Day
- ₹1,985.96
- 200 Day
- ₹1,852.03
- 20 Day
- ₹2,040.82
- 50 Day
- ₹1,998.95
- 100 Day
- ₹2,085.88
- 200 Day
- ₹1,802.81
GlaxoSmithKline Pharmaceuticals Resistance and Support
PIVOT
₹2,218.15
| Resistance | |
|---|---|
| First Resistance | 2,412.10 |
| Second Resistance | 2,537.20 |
| Third Resistance | 2,731.15 |
| RSI | 73.38 |
| MFI | 73.71 |
| MACD Single Line | 10.71 |
| MACD | 24.10 |
| Support | |
|---|---|
| First Support | 2,093.05 |
| Second Support | 1,899.10 |
| Third Supoort | 1,774.00 |
GlaxoSmithKline Pharmaceuticals Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 1,257,362 | 28,227,777 | 22.45 |
| Week | 312,803 | 9,390,334 | 30.02 |
| 1 Month | 174,058 | 7,823,916 | 44.95 |
| 6 Month | 229,725 | 12,784,182 | 55.65 |
GlaxoSmithKline Pharmaceuticals Result Highlights
GlaxoSmithKline Pharmaceuticals Synopsis
NSE-Medical-Diversified
Glaxosmithkline Phar is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 3216.34 Cr. and Equity Capital is Rs. 169.41 Cr. for the Year ended 31/03/2023. GlaxoSmithKline Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 13/11/1924 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1924PLC001151 and registration number is 001151.| Market Cap | 38,743 |
| Sales | 3,407 |
| Shares in Float | 4.24 |
| No of funds | 261 |
| Yield | 1.58 |
| Book Value | 22.1 |
| U/D Vol ratio | 0.7 |
| LTDebt / Equity | |
| Alpha | 0.1 |
| Beta | 0.81 |
GlaxoSmithKline Pharmaceuticals Shareholding Pattern
| Owner Name | Mar-24 | Dec-23 | Sep-23 | Jun-23 |
|---|---|---|---|---|
| Promoters | 75% | 75% | 75% | 75% |
| Mutual Funds | 4.51% | 4.5% | 4.81% | 4.25% |
| Insurance Companies | 3.25% | 4.02% | 5.15% | 5.97% |
| Foreign Portfolio Investors | 3.48% | 2.93% | 2.5% | 2.41% |
| Financial Institutions/ Banks | 0.01% | 0.01% | 0.01% | 0.01% |
| Individual Investors | 11.27% | 11.08% | 10.62% | 10.57% |
| Others | 2.48% | 2.46% | 1.91% | 1.79% |
GlaxoSmithKline Pharmaceuticals Management
| Name | Designation |
|---|---|
| Ms. R S Karnad | Chairperson |
| Mr. B Akshikar | Managing Director |
| Dr.(Ms.) S Maheshwari | Director |
| Mr. S Williams | Director |
| Mr. P V Bhide | Director |
| Mr. A N Roy | Director |
| Mr. D Sundaram | Director |
| Mr. M Anand | Director |
| Mr. J Chandy | Director |
GlaxoSmithKline Pharmaceuticals Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
GlaxoSmithKline Pharmaceuticals Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-05-17 | Audited Results & Final Dividend | |
| 2024-02-12 | Quarterly Results | |
| 2023-11-09 | Quarterly Results | |
| 2023-07-26 | Quarterly Results | |
| 2023-05-17 | Audited Results & Final Dividend |
| Date | Purpose | Remarks |
|---|---|---|
| 2023-06-30 | FINAL | Rs.32.00 per share(320%)Final Dividend |
| 2022-07-08 | FINAL | Rs.30.00 per share(300%)Dividend |
| 2022-07-08 | SPECIAL | Rs.60.00 per share(600%)Special Dividend |
| 2021-07-20 | FINAL | Rs.30.00 per share(300%)Dividend |
GlaxoSmithKline Pharmaceuticals FAQs
What is Share Price of GlaxoSmithKline Pharmaceuticals ?
GlaxoSmithKline Pharmaceuticals share price is ₹2,382 As on 18 May, 2024 | 11:30
What is the Market Cap of GlaxoSmithKline Pharmaceuticals ?
The Market Cap of GlaxoSmithKline Pharmaceuticals is ₹40359.3 Cr As on 18 May, 2024 | 11:30
What is the P/E ratio of GlaxoSmithKline Pharmaceuticals ?
The P/E ratio of GlaxoSmithKline Pharmaceuticals is 68.4 As on 18 May, 2024 | 11:30
What is the PB ratio of GlaxoSmithKline Pharmaceuticals ?
The PB ratio of GlaxoSmithKline Pharmaceuticals is 22.7 As on 18 May, 2024 | 11:30